How well do Cognitive Behavioural Therapy and Behavioural Activation for depression repair anhedonia? A secondary analysis of the COBRA randomized controlled trial.


Journal

Behaviour research and therapy
ISSN: 1873-622X
Titre abrégé: Behav Res Ther
Pays: England
ID NLM: 0372477

Informations de publication

Date de publication:
12 2022
Historique:
received: 28 11 2021
revised: 19 08 2022
accepted: 19 08 2022
pubmed: 14 11 2022
medline: 7 12 2022
entrez: 13 11 2022
Statut: ppublish

Résumé

A secondary analysis of the COBRA randomized controlled trial was conducted to examine how well Cognitive Behavioural Therapy (CBT) and Behavioural Activation (BA) repair anhedonia. Patients with current major depressive disorder (N = 440) were randomized to receive BA or CBT, and anhedonia and depression outcomes were measured after acute treatment (six months) and at two further follow up intervals (12 and 18 months). Anhedonia was assessed using the Snaith Hamilton Pleasure Scale (SHAPS; a measure of consummatory pleasure). Both CBT and BA led to significant improvements in anhedonia during acute treatment, with no significant difference between treatments. Participants remained above healthy population averages of anhedonia at six months, and there was no further significant improvement in anhedonia at 12-month or 18-month follow up. Greater baseline anhedonia severity predicted reduced repair of depression symptoms and fewer depression-free days across the follow-up period in both the BA and CBT arms. The extent of anhedonia repair was less marked than the extent of depression repair across both treatment arms. These findings demonstrate that CBT and BA are similarly and only partially effective in treating anhedonia. Therefore, both therapies should be further refined or novel treatments should be developed in order better to treat anhedonia.

Identifiants

pubmed: 36371903
pii: S0005-7967(22)00156-5
doi: 10.1016/j.brat.2022.104185
pii:
doi:

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104185

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no affiliation with any organization with a direct or indirect financial interest in the subject matter discussed in the manuscript (TRUE).

Auteurs

Batool Alsayednasser (B)

Mood Disorders Centre, University of Exeter, UK.

Emily Widnall (E)

Bristol Medical School, University of Bristol, UK.

Heather O'Mahen (H)

Mood Disorders Centre, University of Exeter, UK.

Kim Wright (K)

Mood Disorders Centre, University of Exeter, UK.

Fiona Warren (F)

College of Medicine and Health, University of Exeter, UK.

Asha Ladwa (A)

Mood Disorders Centre, University of Exeter, UK.

Gabriela Kattan Khazanov (GK)

Corporal Michael J. Crescenz VA Medical Center, USA.

Sarah Byford (S)

Health Service & Population Research Department, Kings College London, UK.

Willem Kuyken (W)

Department of Psychiatry, University of Oxford, UK.

Ed Watkins (E)

Mood Disorders Centre, University of Exeter, UK.

David Ekers (D)

Department of Health Science, University of York, UK; Tees Esk and Wear Valleys NHS Foundation Trust, UK.

Nigel Reed (N)

Mood Disorders Centre, University of Exeter, UK.

Emily Fletcher (E)

College of Medicine and Health, University of Exeter, UK.

Dean McMillan (D)

Department of Health Sciences and Hull York Medical School, University of York, UK.

Paul Farrand (P)

CEDAR, University of Exeter, UK.

David Richards (D)

College of Medicine and Health, University of Exeter, UK; Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Norway.

Barnaby D Dunn (BD)

Mood Disorders Centre, University of Exeter, UK. Electronic address: b.d.dunn@exeter.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH